PCOS does not simply disappear at menopause. The hormone picture changes, but the underlying metabolic features — insulin resistance in particular — often persist, and they can matter more for long-term health after menopause than irregular periods did before it. There is no single treatment protocol designed specifically for PCOS after menopause. Care usually focuses on managing whatever is still active: blood sugar, cholesterol, blood pressure, weight, and cardiovascular risk. Some standard PCOS treatments, like combined hormonal birth control, are generally no longer appropriate at this stage.
Does PCOS Go Away After Menopause?
No. The menstrual irregularity that defines PCOS in younger women resolves because periods stop for everyone at menopause. But the diagnosis was never only about periods.
PCOS is a metabolic and endocrine condition with reproductive features. Research consistently shows that insulin resistance and the associated risk of type 2 diabetes persist in many women with PCOS well past menopause. A woman can have perfectly regular (or absent) cycles and still carry the metabolic profile that made PCOS relevant in the first place.
One point that gets lost: PCOS is diagnosed using the Rotterdam criteria, which require two of three findings — irregular ovulation, elevated androgens on testing or exam, and polycystic ovaries on ultrasound. After menopause, the ovarian finding and the cycle finding no longer apply in the same way. So a woman isn’t “diagnosed” with PCOS after menopause so much as she carries a history of it forward. That distinction matters for how care is framed.
What Happens to PCOS Hormones After Menopause?
The hormonal environment shifts substantially. Estrogen falls sharply with the end of ovarian function. Testosterone also declines with age, though some women with PCOS retain relatively higher levels than peers without it.
Before menopause, much of the elevated testosterone in PCOS comes from the ovaries. After menopause, the adrenal glands and peripheral fat tissue become relatively more important sources. This is why some women notice that acne and unwanted hair growth improve, while others don’t. The pattern varies.
Sex hormone binding globulin (SHBG) tends to rise after menopause, which changes how much testosterone is biologically active. The practical result is that androgen symptoms often — but not always — soften. This is one area where the evidence is genuinely mixed and individual outcomes differ widely.
What Are the Main Health Risks of PCOS After Menopause?
The risks that matter most after menopause are cardiometabolic. They are not new — they were present before menopause too — but they carry more weight as baseline cardiovascular risk rises with age.
- Type 2 diabetes. Insulin resistance is a core feature of PCOS, and studies have found a higher rate of type 2 diabetes in women with PCOS compared with women without it. This risk does not appear to fade after menopause.
- Cardiovascular disease. PCOS is associated with higher blood pressure, adverse lipid patterns, and increased markers of cardiovascular risk. The evidence for a higher rate of heart events is suggestive but has been harder to pin down precisely in long-term studies.
- Metabolic syndrome. Clustering of high blood pressure, elevated blood sugar, abnormal cholesterol, and abdominal weight gain is more common in women with a PCOS history.
- Endometrial cancer. This is a pre-menopausal concern linked to long stretches of unopposed estrogen from anovulation. After menopause, the risk profile changes and this specific mechanism no longer applies in the same way.
The honest position on cardiovascular outcomes: the association with risk factors is well established, but the link to actual heart attacks and strokes in women with PCOS is less firmly quantified. That doesn’t make the risk factors unimportant — it means the risk factors themselves are the thing to manage.
How Is PCOS Managed After Menopause?
Management targets the features that are still active. There is no dedicated post-menopausal PCOS guideline, so clinicians generally apply standard cardiovascular and diabetes prevention guidance to a woman with this history.
Blood sugar screening is a reasonable starting point. Standard screening for type 2 diabetes uses fasting glucose, HbA1c, or an oral glucose tolerance test. Because insulin resistance is central to PCOS, some clinicians favor periodic screening rather than waiting for symptoms. How often to screen is a clinical judgment call, not a fixed rule.
Cardiovascular risk factors — blood pressure, lipids, weight — get the same attention they would for anyone at elevated risk. Statins, antihypertensive medications, and other interventions follow standard guidelines based on measured values, not on PCOS status alone.
Weight management is often discussed, and the evidence does support that modest weight loss can improve insulin sensitivity. That said, framing weight as the primary solution oversimplifies a condition with strong genetic and hormonal drivers. Sustainable changes to diet and activity tend to matter more than any single number on a scale.
Physical activity has reasonable evidence for improving insulin sensitivity in PCOS. Both aerobic and resistance training have been studied. General physical activity guidelines for adults apply.
Which PCOS Treatments Are No Longer Appropriate After Menopause?
Combined hormonal contraceptives — the pill, patch, and ring — are the mainstay of PCOS management in reproductive years, largely to regulate cycles and protect the uterine lining. After menopause, that purpose no longer exists.
Hormonal contraceptives also carry cardiovascular risks that increase with age, particularly in women who smoke or have other risk factors. Most clinical guidance does not recommend starting them for PCOS management after menopause. If a woman is already on one for another reason, that decision belongs with her clinician.
Metformin is a different story. It has been studied in PCOS for insulin resistance and is sometimes used in women with prediabetes or type 2 diabetes. Its use after menopause would generally follow diabetes prevention or treatment guidance rather than PCOS-specific guidance. Some clinicians prescribe it; the evidence for PCOS-specific benefit after menopause is limited.
Anti-androgen medications like spironolactone are sometimes used for acne and hair growth. After menopause, these symptoms often improve on their own, and the risk-benefit balance shifts. This is a conversation to have with a clinician, not a decision to make from a general article.
Is Menopausal Hormone Therapy an Option With a PCOS History?
Possibly, but it depends on why it’s being considered. Menopausal hormone therapy (MHT) is used to relieve symptoms like hot flashes and vaginal dryness, and it has established benefits for those symptoms. It is not a treatment for PCOS.
For women with a PCOS history, the main question is whether MHT is appropriate for their menopausal symptoms and their individual risk profile. A history of PCOS does not automatically rule MHT in or out. Cardiovascular risk, blood pressure, smoking status, and personal and family history all factor into the decision. This is a genuinely individualized call.
One clarification worth stating plainly: MHT is not the same as the birth control pill, even though both contain hormones. The doses, the types of estrogen and progestogen, and the clinical purposes differ. Conflating them leads to confusion about risk.
What Should Women With a PCOS History Actually Do?
Know your numbers. Fasting glucose, HbA1c, blood pressure, and a lipid panel give a clear picture of where things stand. These are the measurements that drive most of the decisions that matter after menopause.
Tell your clinician about the PCOS history, even if it was diagnosed decades ago. It is relevant context for screening decisions and cardiovascular risk assessment. Many women assume it’s water under the bridge once periods stop. It isn’t.
Be skeptical of supplements marketed for “hormone balance” or “PCOS support.” No clinical evidence currently confirms that these products treat PCOS or reduce its long-term risks. The evidence base for most is thin to absent.
Watch for symptoms that warrant attention: unusual fatigue, increased thirst or urination, unexplained weight change, or new blood pressure readings. These can signal metabolic changes worth evaluating.
Frequently Asked Questions
Can you still have PCOS after menopause?
Yes. The condition doesn’t resolve at menopause, though the menstrual symptoms stop. The metabolic features, especially insulin resistance, often persist and remain clinically relevant.
Does PCOS increase health risks after menopause?
Research consistently shows a higher risk of type 2 diabetes and cardiovascular risk factors in women with PCOS. The link to actual heart events is less firmly quantified, but the risk factors themselves warrant attention.
Is hormone replacement therapy safe if you have PCOS?
It depends on individual risk factors, not on PCOS status alone. Whether MHT is appropriate is a decision to make with a clinician based on symptoms, cardiovascular risk, and personal history.
Should you take metformin for PCOS after menopause?
Not routinely. Metformin is generally used when there is prediabetes or type 2 diabetes, following standard diabetes guidance rather than PCOS-specific recommendations.

